• A 1-year-old child with essential thrombocythemia
• A 27-Year-Old Female With JAK2 Mutation: A Case of Budd-Chiari Syndrome Secondary to Prolonged Oral Contraceptive Pill Use
• A Case of acute Myocardial Infarction in a Patient with Essential Thrombocythaemia Treated with Anagrelide
• A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Coexistence of the <em>JAK2V617F</em> Clone
• A Case Report on the Utilization of a Hemostasis Analyzer System in the Management of a Patient With Essential Thrombocythemia
• A rare case of essential thrombocythemia with pseudo-hyperkalemia
• A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy
• A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients With Myeloproliferative Neoplasms Scheduled for Surgery
• A thromboembolic event as the first presentation of essential thrombocytosis: A case report
• Acquired von Willebrand Syndrome in a 17-Year-Old With Essential Thrombocythemia: A Case Report With Literature Review
• Acute invasive fungal sinusitis with orbital tip syndrome in patients on long-term use of ruxolitinib: a case report
• Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review
• ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms
• Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine
• An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
• Analysis of CHIP-Related Mutation and Risk of Cardio-Cerebrovasculars Events in Patients with Myeloproliferative Neoplasms
• Analysis of the factors influencing the severity of coronavirus disease 2019 in patients with myeloproliferative neoplasms based on an online questionnaire
• Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies
• Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?
• Assessment of Total Antioxidant Capacity, 8-Hydroxy-2'-deoxy-guanosine, the Genetic Landscape, and Their Associations in <em>BCR::ABL-1</em>-Negative Chronic and Blast Phase Myeloproliferative Neoplasms
• Bleeding heralding the diagnosis of essential thrombocythemia
• Broad next generation integrated sequencing of myelofibrosis identifies disease-specific and age-related genomic alterations
• Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations
• C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms
• CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia
• CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
• Calreticulin-Enigmatic Discovery
• Case report: Effectiveness of low-dose methotrexate monotherapy in post-essential thrombocythemia myelofibrosis
• Childbirth rates in women with myeloproliferative neoplasms
• Chronic myeloproliferative neoplasms with concomitant <em>CALR</em> mutation and <em>BCR::ABL1</em> translocation: diagnostic and therapeutic implications of a rare hybrid disease
• Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea
• Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis
• Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
• Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice
• Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the CALR-mutated Marimo cell line was established
• Comparison of Clinical Characteristics of JAK2, CALR and Tri-Negative Driving Mutant Type in Patients with Essential Thrombocythemia
• Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression
• Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axis
• Direct and indirect costs for patients with myeloproliferative neoplasms
• Essential thrombocythaemia: A contemporary approach with new drugs on the horizon
• Essential thrombocythemia with MPL W515S mutation
• Essential thrombocythemia: nutritional management in weight loss and malnutrition
• Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis
• Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients
• Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus
• Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms
• Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
• Inflammation as a cause of acute myocardial infarction in patients with myeloproliferative neoplasm
• Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity
• Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia
• Interferons in the treatment of myeloproliferative neoplasms
• Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis
• Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial
• Management of Essential Thrombocythemia in a Patient With a History of Thrombotic Thrombocytopenic Purpura
• Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case report
• Merkel Cell Carcinoma on the Face: A Case Report
• Merkel Cell Carcinoma on the Face: Case Report
• Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
• Myeloproliferative Neoplasms Transcriptome Reveals Pro-Inflammatory Signature and Enrichment in Peripheral Blood Monocyte-Related Genes
• Near-early T-cell precursor acute lymphoblastic leukemia following a diagnosis of essential thrombocythemia
• Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms
• Platelet Factor 4 and Longevity of Patients with Essential Thromobocythemia: An Example of Antagonistic Pathogenic Pleiotropy
• Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
• Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach
• Polyglobulie essentielle et hypertension portale non cirrhotique diagnostiquées en cours de grossesse
• Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
• Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India
• Pseudo-lymphocytosis caused by circulating megakaryocyte fragments in a patient with post-essential thrombocythemia myelofibrosis
• Queries regarding the two papers each reporting on 1000 essential thrombocythemia patients in BCJ
• Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths
• Reactive Thrombocytosis: A Bizarre Consequence of Splenectomy
• Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores
• Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
• Recent findings and advances in treatment of myeloproliferative neoplasms
• Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms
• Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms
• Renal tubular necrosis associated with anagrelide administration: a case report
• Repeated Ischemic Stroke due to in situ Thrombus at the Middle Cerebral Artery in a Patient with Essential Thrombocythemia
• Resveratrol and tetrahydroisoquinoline effects on neutrophil sensitivity to NETosis formation in low-risk essential thrombocythemia patients
• Retinal Vessel Analysis and Microvascular Abnormalities in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
• Retinochoroiditis secondary to Rickettsia typhi infection: a case report
• Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms
• Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: A nationwide longitudinal cohort study
• ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
• Sailing in deceptive calm: Navigating the undercurrents of essential thrombocythaemia
• Sex-specific impact on disease outcome and the mutational landscape in essential thrombocythemia: A retrospective cohort study
• SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms
• Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis
• Successful management of VTE with essential thrombocythemia and cavernous transformation of the portal vein in early pregnancy: a case report
• The Burden of symptoms and Quality of life of Filipino patients with Myeloproliferative neoplasm: A Multicenter Cross-sectional survey
• The characteristics of <em>CALR</em> mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review
• The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms
• The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia
• The personal impact of living with a myeloproliferative neoplasm
• The Role of DNA Repair (<em>XPC</em>, <em>XPD</em>, <em>XPF</em>, and <em>XPG)</em> Gene Polymorphisms in the Development of Myeloproliferative Neoplasms
• Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events
• Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms
• Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report
• Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form-Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire
• Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study